Search results
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 21 hours agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic...
Nature· 21 hours agoDelivering bacteria-based drug for cancer therapy is limited by their penetration into extracellular matrix (ECM). Here the authors report effective depletion of ECM with ...
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg via Yahoo Finance· 12 hours ago(Bloomberg) -- The Food and Drug Administration delayed a breast- and lung-cancer trial of an...
Their cancers can't be cured. But new treatments are increasing the length, and quality, of their...
Milwaukee Journal Sentinel via Yahoo News· 5 days ago"We want to take away the guesswork to the extent possible that technology allows us, and them give...
How a well-traveled brain cancer drug turned into an $8 million payday for an East Bay firm - San...
The Business Journals· 10 hours agoA drug traded between companies for 20 years — and approved by regulators in April to treat brain...
Study reveals unexpected mechanism of drug resistance in kidney cancer
Medical Xpress· 6 days agoRapalogs (or rapamycin analogs) are used to treat renal cell carcinoma (RCC) and other tumor types, but their utility is hindered because tumors become resistant over time ...
What does malignant mean? And why it matters greatly when it comes to tumors and your health.
USA TODAY via Yahoo News· 2 days agoIn other words, when a doctor talks about a tumor being malignant, it's the same as them saying cancer is present. Once discovered, "malignant tumors generally require treatment ...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 5 days agoThis surge in interest, he points out, underscores a wider recognition that radiopharmaceuticals offer “a fundamentally different...radioactivity decays....
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with...
Morningstar· 14 hours agoReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncology indications, and Asieris Pharmaceuticals ...
Swimming microrobots deliver cancer-fighting drugs to metastatic lung tumors in mice
Science Daily· 6 days agoThe microrobots are an ingenious combination of biology and nanotechnology. To create the microrobots, researchers chemically attached drug-filled nanoparticles to the surface ...